Suppr超能文献

当地心脏康复服务中脂质管理途径的评估。

Evaluation of a lipid management pathway within a local cardiac rehabilitation service.

作者信息

Jones Claire

机构信息

Advanced Practitioner in Cardiac Rehabilitation Cardiac Rehabilitation, Clwydian House, Wrexham Maelor Hospital, Croesnewydd Road, Wrexham, LL13 7TD.

出版信息

Br J Cardiol. 2022 Nov 9;29(4):34. doi: 10.5837/bjc.2022.034. eCollection 2022.

Abstract

Elevated cholesterol/lipid levels, especially low-density lipoprotein cholesterol (LDL-C) are known to contribute to the development of atherosclerotic cardiovascular disease (ASCVD). The attainment of lipid targets is known to be suboptimal both globally and locally. This study aimed to evaluate the effectiveness of a lipid management pathway (LMP) in supporting attainment of lipid targets following an acute coronary syndrome (ACS) in a local cohort of cardiac rehabilitation (CR) patients. Quantitative data were retrospectively collected from 54 CR patient records. Local lipid target attainment was benchmarked against national guidelines and pre-pathway implementation audit results. The number of admission lipid profiles increased by 24.8% to 79.6% following implementation of the LMP. There was a 31% improvement in the number of patients achieving either a 50% reduction in LDL-C or an LDL-C level of <1.4 mmol/L. In conclusion, the LMP had a significant positive impact upon the attainment of lipid goals.

摘要

众所周知,胆固醇/血脂水平升高,尤其是低密度脂蛋白胆固醇(LDL-C)会导致动脉粥样硬化性心血管疾病(ASCVD)的发生。在全球和本地,达到血脂目标的情况都不太理想。本研究旨在评估脂质管理途径(LMP)在支持当地心脏康复(CR)患者急性冠状动脉综合征(ACS)后达到血脂目标方面的有效性。从54份CR患者记录中回顾性收集定量数据。将当地血脂目标达成情况与国家指南和途径实施前的审计结果进行对比。实施LMP后,入院血脂检测的次数增加了24.8%,达到79.6%。实现LDL-C降低50%或LDL-C水平<1.4 mmol/L的患者数量提高了31%。总之,LMP对实现血脂目标有显著的积极影响。

相似文献

1
Evaluation of a lipid management pathway within a local cardiac rehabilitation service.
Br J Cardiol. 2022 Nov 9;29(4):34. doi: 10.5837/bjc.2022.034. eCollection 2022.
3
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y.

引用本文的文献

2
Secondary prevention lipid management following ACS: a missed opportunity?
Br J Cardiol. 2022 Nov 9;29(4):35. doi: 10.5837/bjc.2022.035. eCollection 2022.
3
A Systematic Review of Lipid Management in Secondary Prevention and Comparison of International Lipid Management Pathways.
Cureus. 2023 Feb 25;15(2):e35463. doi: 10.7759/cureus.35463. eCollection 2023 Feb.

本文引用的文献

2
An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study.
Front Pharmacol. 2020 Mar 18;11:326. doi: 10.3389/fphar.2020.00326. eCollection 2020.
7
Attainment of lipid goals and long-term mortality after coronary-artery bypass surgery.
Eur J Prev Cardiol. 2019 Mar;26(4):401-408. doi: 10.1177/2047487318812962. Epub 2018 Nov 14.
8
9
Interpretation of the evidence for the efficacy and safety of statin therapy.
Lancet. 2016 Nov 19;388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5. Epub 2016 Sep 8.
10
Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk.
Clin Res Cardiol. 2016 Sep;105(9):783-90. doi: 10.1007/s00392-016-0991-z. Epub 2016 Apr 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验